- Alemtuzumab, sold
under the
brand names Campath and
Lemtrada among others, is a
medication used to
treat chronic lymphocytic leukemia and
multiple sclerosis...
- prednisone, etoposide, cyclophosphamide,
bleomycin VAPEC-B).
Alemtuzumab (
Campath), a
monoclonal antibody that
attacks white blood cells, has been used in...
- to
directly target components of the TCR/CD3 complex, Alemtuzumab, or
Campath-1H, has been
utilized because of its
strong ability to
deplete T cells...
-
variant notation for AR C****iopeiae UH-1H, a type of Bell UH-1
Iroquois Campath-1H, a
brand of
Alemtuzumab Ardiden 1H, a
model of HAL/Turbomeca Shakti...
-
GlaxoSmithKline and now
owned by Mylan.
Cablivi (Caplacizumab), for thrombosis.
Campath (Alemtuzumab), for
multiple sclerosis.
Clolar (Clofarabine), for leukemia...
-
Conventional radiation therapy Photopheresis Interferons Alemtuzumab (
Campath-1H)
Methotrexate Pentostatin and
other purine analogues (Fludarabine,...
-
CAMPATH-1 antigen, also
known as
cluster of
differentiation 52 (CD52), is a
glycoprotein that in
humans is
encoded by the CD52 gene. CD52 is
present on...
- case, a
monoclonal dubbed "
Campath-1" was
developed to bind CD52
using a
mouse system. The
hypervariable loops of
Campath-1 (that
contain its CDRs and...
-
disease and
graft rejection by T cell
depletion of
donor and
recipient with
Campath-1 antibodies.
Results of
matched sibling transplants for
malignant diseases"...
- in
development are
Tolevamer for
Clostridioides difficile infection and
Campath for
Chronic lymphocytic leukemia.
Genzyme had a sub-license from Bioenvision...
